Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling

NCT00161278 ·Status: TERMINATED ·Phase: PHASE2

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

NCT01817192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

NCT01237678 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

NCT00020202 ·Status: COMPLETED ·Phase: PHASE2

MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer

NCT06227546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

NCT06961201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

NCT05728619 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00022009 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

NCT02252796 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer

NCT06592638 ·Status: RECRUITING ·Phase: PHASE1

Pazopanib in Molecularly Selected Patients With Advanced NSCLC

NCT02193152 ·Status: TERMINATED ·Phase: PHASE2

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma

NCT00483509 ·Status: COMPLETED ·Phase: PHASE2

Molecular Disease Characterization Initiative (MDCI)

NCT04772053 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

NCT00042679 ·Status: COMPLETED ·Phase: PHASE2

A Prevention Trial of Canakinumab in Subjects at High Risk for Lung Cancer

NCT05725343 ·Status: TERMINATED ·Phase: PHASE3

A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

NCT05775289 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

NCT00760929 ·Status: TERMINATED ·Phase: PHASE2

A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

NCT05358691 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

NCT05543629 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

NCT00099879 ·Status: TERMINATED ·Phase: PHASE2

A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments

NCT01529112 ·Status: COMPLETED ·Phase: PHASE2

Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer

NCT00705549 ·Status: TERMINATED ·Phase: PHASE2

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]

NCT06585189 ·Status: COMPLETED

Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation

NCT00858403 ·Status: TERMINATED ·Phase: PHASE2

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

NCT01222572 ·Status: TERMINATED ·Phase: PHASE1/PHASE2